The Thymic Insulin-like Growth Factor Axis: Involvement in Physiology and Disease

Hormone and Metabolic Research

Volumn 35, Issue 11-12, 2003, Pages 656-663

  Geenen, V ^a,b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Lab of Neuroendocrine Immunology   (Belgium)

Author keywords

Autoimmunity; Self tolerance; T cell leukemia; Thymus epithelium; Tolerogenic vaccine; Type 1 diabetes

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CARCINOGENESIS; CELL MATURATION; CELLULAR DISTRIBUTION; CYTOKINE RELEASE; DIABETES MELLITUS; EPITHELIUM CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MOLECULAR BIOLOGY; NEUROENDOCRINE SYSTEM; NEUROSECRETORY CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSIOLOGY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; T LYMPHOCYTE; THYMUS;

ANIMALS; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNE TOLERANCE; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0347986564     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-814161     Document Type: Article

References (83)

1. th Edition. Philadelphia: Lippin-cott-Raven, 1999: 367-409
2. Mason D, Powrie F. Control of immune pathology by regulatory T-cells. Curr Opin Immunol 1998; 10: 649-655
3. Sakagushi S. Policing the regulators. Nat Immunol 2001; 2: 283-284
4. Kamradt T, Mitchison NA. Tolerance and autoimmunity. N Engl J Med 2001; 344: 655-664
5. Bennett AR, Farley A, Blair NF, Gordon J, Sharp L, Blackburn CC. Identification and characterization of thymic epithelial progenitor cells. Immunity 2002; 16: 803-814
6. Girr J, Malin M, Holländer GA, Boyd R. Generation of a complete thymic microenvironment by MTS24+ thymic epithelial cells. Nat Immunol 2002; 3: 635-642
7. Penninger J, Rieker T, Romani N, Klima J, Salvenmoser W, Dietrich H, Stössel H, Wick G. Ultrastructural analysis of thymic nurse cell epithelium. Eur J Immunol 1993; 24: 222-229
8. Lorenz RG, Allen PM. Thymic cortical epithelial cells can present self-antigens in vivo. Nature 1989; 337: 560-562
9. Ashton-Rickardt PG, Tonegawa S. A differential-affinity model for T-cell selection. Immunol Today 1994; 15: 362-366
10. Geenen V, Robert F, Martens H, De Groote D, Franchimont P. The thymic education of developing T-cells in self neuroendocrine principles. J Endocr Invest 1992; 15: 621-629
11. Robert F, Martens H, Cormann N, Benhida A, Schoenen J, Geenen V. The recognition of hypothalamo-neurohypophysial functions by developing T-cells. Dev Immunol 1992; 2: 131-140
12. Jolicoeur C, Hanahan D, Smith KM. T-cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous genes in the thymus. Proc Natl Acad Sci USA 1994; 91: 6707-6711
13. Hanahan D. Peripheral-antigen-expressing cells in thymus medulla: factors in self-tolerance and autoimmunity. Curr Opin Immunol 1998; 10: 656-662
14. Savino W, Dardenne M. Neuroendocrine control of thymus physiology. Endocr Rev 2000; 21: 412-443
15. Kyewski B, Derbinski J, Gotter J, Klein L. Promiscuous gene expression and central T-cell tolerance: more than meets the eye. Trends Immunol 2002; 23: 364-371
16. Geenen V, Legros JJ, Franchimont P, Baudrihaye M, Defresne MP, Boniver J. The thymus as a neuroendocrine organ: coexistence of oxytocin and neurophysin in the human thymus. Science 1986; 232: 508-511
17. Ericsson A, Geenen V, Robert F, Legros JJ, Vrindts-Gevaert Y, Franchimont P, Brene S, Persson H. Expression of preprotachykinin-A and neuropeptide-Y messenger RNA in the thymus. Mol Endocr 1990; 4: 1211-1218
18. Funder JW. Paracrine, cryptocrine, acrocrine. Mol Cell Endocrinol 1990; 70: C21-C24
19. Geenen V, Goxe B, Martens H, Vandersmissen E, Vanneste Y, Achour I, Kecha O, Lefebvre PJ. Cryptocrine signaling in the thymus network and T-cell education to neuroendocrine self-antigens. J Mol Med 1995; 73: 449-455
20. Geenen V, Vandersmissen E, Martens H, Cormann-Goffin N, Degiovanni G, Legros JJ, Benhida A, Martial J, Franchimont P. Membrane translocation and association with MHC class I of a human thymic neurophysin-like protein. Thymus 1993; 22: 55-66
21. Vanneste Y, Ntodou-Thome A, Vandersmissen E, Charlet C, Franchimont D, Martens H, Schimpff RM, Rostene W, Geenen V. Identification of neurotensin-related peptides in human thymic epithelial cell membranes and relationship with major histocompatibility complex class I molecules. J Neuroimmunol 1997; 76: 161-166
22. rd Edition. New York: Elsevier, 2003: in press
23. Geenen V, Achour I, Robert F, Vandersmissen E, Sodoyez JC, Defresne MP, Boniver J, Lefebvre PJ, Franchimont P. Evidence that insulin-like growth factor-2 (IGF-II) is the dominant thymic peptide of the insulin superfamily. Thymus 1993; 21: 115-127
24. van Buul-Offers SC, de Haan K, Reijnen-Gresnigt MG, Meinsma D, Jansen M, Oei SL, Bonte EJ, Sussenbach JS, Van den Brande JL. Overexpression of human insulin-like growth factor-II in transgenic mice causes increased growth of the thymus. J Endocrinol 1995; 144: 491-502
25. Van der Ven LTM, Roholl PJM, Reijnen-Gresnigt MG, Bloemen RJ, van Buul-Offers SC. Expression of insulin-like growth factor II (IGF-II) and histological changes in the thymus and spleen of transgenic mice overexpressing IGF-II. Histochem Cell Biol 1997; 107: 193-203
26. Kooijman R, van Buul-Offers SC, Scholtens LE, Schuurman HJ, van den Brande LJ, Zegers BJM. T-cell development in insulin-like growth factor-II transgenic mice. J Immunol 1995; 154: 5736-5745
27. Kecha O, Martens H, Franchimont N, Achour I, Hazée-Hagelstein MT, Charlet-Renard C, Geenen V, Winkler R. Characterization of the insulin-like growth factor axis in the human thymus. J Neuroendocrinol 1999; 11: 435-440
28. Montecino-Rodriguez E, Clark R, Dorshkind K. Effects of insulin-like growth factor administration and bone marrow transplantation on thymopoiesis in aged mice. Endocrinology 1998; 139: 4120-4126
29. Kecha O, Brilot F, Martens H, Franchimont N, Renard C, Greimers R, Defresne MP, Winkler R, Geenen V. Involvement of insulin-like growth factors in early T-cell development: a study using fetal thymic organ cultures. Endocrinology 2000; 141: 1209-1217
30. Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2001; 2: 1032-1039
31. Egwuagu CE, Charukamnoetkanok P, Gery I. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J Immunol 1997; 159: 3109-3112
32. Sospedra M, Ferrer-Francesch X, Dominguez O, Juan M, Foz-Sala M, Pujol-Borrell R. Transcription of a broad range of self-antigens in human thymus suggests a role for central mechanism in tolerance towards peripheral antigens. J Immunol 1998; 161: 5918-5929
33. Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG, Wickramasinghe S, Colle E, Polychronakos C. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 1997; 15: 289-292
34. Pugliese A, Zeller M, Fernandez A Jr, Zalcberg LJ, Bartlett RJ, Ricordi C, Pietropaolo M, Eisenbarth GS, Bennett ST, Patel DD. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997; 15: 293-297
35. Zapf J, Walter H, Froesch ER. Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J Clin Invest 1981; 68: 1321-1330
36. Naquet P, Ellis J, Tibensky D, Kenshole A, Singh B, Hodges R, Delovitch TL. T-cell autoreactivity to insulin in diabetic and related non-diabetic individuals. J Immunol 1988; 140: 2569-2578
37. Like AA, Kislaukis E, Williams RM, Rossini AA. Neonatal thymectomy prevents spontaneous diabetes mellitus in the BB:W rat. Science 1982; 216: 644-646
38. Georgiou HM, Bellgrau D. Thymus transplantation and disease prevention in the diabetes-prone Bio-Breeding rat. J Immunol 1989; 142: 3400-3405
39. Georgiou HM, Mandel TE. Induction of insulitis in athymic (nude) mice. The effect of NOD thymus and pancreas transplantation. Diabetes 1995; 44: 49-59
40. Hosaka N, Nose M, Kyogoku M, Nagata N, Miyashima S, Good RA, Ikehara S. Thymus transplantation, a critical factor for correction of autoimmune disease in aging MRL/+ mice. Proc Natl Acad Sci USA 1996; 93: 8558-8562
41. Thomas-Vaslin V, Damotte D, Coltey M, Le Douarin NM, Coutinho A, Salaün J. Abnormal T-cell selection on NOD thymic epithelium is sufficient to induce autoimmune manifestations in C57BL/6 athymic nude mice. Proc Natl Acad Sci USA 1997; 94: 4598-4603
42. Savino W, Carnaud C, Luan JJ, Bach JF, Dardenne M. Characterization of the extracellular matrix-containing giant perivascular spaces in the NOD mouse thymus. Diabetes 1993; 42: 134-140
43. Doukas J, Mordes JP, Swymer C, Niedzwiecki D, Mason R, Rozing J, Rossini AA, Greiner DL. Thymic epithelial defects and predisposition to autoimmune disease in BB rats. Am J Pathol 1994; 145: 1517-1525
44. Kecha-Kamoun O, Achour I, Martens H, Collette J, Lefebvre PJ, Greiner DL, Geenen V. Thymic expression of insulin-related genes in an animal model of type 1 diabetes. Diabetes/Metab Res Rev 2001; 17: 146-152
45. Brimnes MK, Jensen T, Jorgensen TN, Michelsen BK, Troelsen J, Werdenlin O. Low expression of insulin in the thymus of non-obese diabetic mice. J Autoimmun 2002; 19: 203-213
46. Chentoufi AA, Polychronakos C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 2002; 51: 1383-1390
47. Thebault-Baumont K, Dubois-Laforgue D, Krief P, Briand JP, Halbout P, Vallon-Geoffroy K, Morin J, Laloux V, Lehuen A, Carel JC, Jami J, Muller S, Boitard C. Acceleration of type 1 diabetes in proinsulin 2 deficient mice. J Clin Invest 2003; 111: 851-857
48. Kaufman DL, Clare-Salzler MC, Tian J, Forsthuber T, Ting GSP, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993; 366: 69-72
49. Diez J, Park Y, Zeller M, Brown D, Garza D, Ricordi C, Hutton J, Eisenbarth GS, Pugliese A. Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen. Diabetes 2001; 50: 895-900
50. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJE, Lalioti MD, Mullis PE, Antonorakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N. Positional cloning of the APECED gene. Nat Genet 1997; 17: 393-398
51. Rossier ML, Heino M, Peterson P, Krohn KJ, Gos A, Morris MA, Kudoh J, Shimizu N, Antonarakis SE, Scott HS. Isolation and characterization of the mouse Aire gene. Biochem Biophys Res Commun 1999; 255: 483-490
52. Pitkänen J, Peterson P. Autoimmune regulator: from loss of function to autoimmunity. Genes and Immunity 2003; 4: 12-21
53. Zuklys S, Balciunaite G, Agarwal A, Farler-Kan E, Palmer E, Holländer GA. Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in the autoimmune- polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). J Immunol 2000; 165: 1976-1983
54. Heino M, Peterson P, Silanpää N, Guerin S, Wu L, Anderson G, Scott HS, Antonarakis SE, Kudoh J, Shimizu N, Jenkinson EJ, Naquet P, Krohn KJ. RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB-deficient and in NOD mouse. Eur J Immunol 2000; 30: 1884-1893
55. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D. Projection of an immunological self shadow in the thymus by the Aire protein. Science 2002; 298: 1395-1301
56. Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC. Aire regulates negative selection of organ-specific T-cells. Nat Immunol 2003; 4: 350-354
57. Burnet FM. A reassessment of the forbidden clone hypothesis of autoimmune diseases. Aust J Exp Biol Med Sci 1973; 50: 1-9
58. Gottlieb PA, Eisenbarth GS. Insulin-specific tolerance in diabetes. Clin Immunol 2002; 102: 2-11
59. Liu E, Moriyama H, Abiru N, Miao D, Yu L, Taylor RM, Finkelman FD, Eisenbarth GS. Anti-peptide antibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B: 13-23. J Clin Invest 2002; 110: 1021-1027
60. Chaillous L, Lefevre H, Thivolet C, Boitard C, Lahlou N, Atlan-Gegner C, Bouhanick B, Mogenet A, Nicolino M, Carel JC, Lecomte P, Marchenaud R, Bougneres P, Charbonnel B, Sai P. Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomized controlled trial. Diabetes Insulin Oral Group. Lancet 2000; 356: 545-549
61. Pozzilli P, Pitocco D, Visalli N, Cavallo MG, Buzzetti R, Crino A, Spera S, Suraci C, Multari G, Cervoni M, Manca Bitti ML, Matteoli MC, Marietti G, Ferrazzoli F, Cassone Faldetta MR, Giordano C, Sbriglia M, Sarugeri E, Ghirlanda G. No effect of oral insulin on residual beta-cell function in recent-onset type 1 diabetes. Diabetologia 2000; 43: 1000-1004
62. DFT-Type 1 diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes. N Engl J Med 2002; 346: 1685-1691
63. Alleva DG, Crowe PD, Jin L, Kwok VW, Ling N, Gottschalk M, Conlon PJ, Gottlieb PA, Putman AL, Gaur A. A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest 2001; 107: 173-180
64. Geenen V, Brilot F, Hansenne I, Louis C, Martens H, Wücherpfennig K, Gorus F. Thymus tolerance dysfunction in the development of the autoimmune diabetogenic response: a way for a novel type of vaccine/immunotherapy. Diabetologia 2003; 46 (suppl. 2): A10, abstract 22
65. Nossal GJV. Vaccination and autoimmunity. J Autoimmun 2000; 14: 13-15
66. Geenen V, Poulin JF, Dion ML, Martens H, Castermans E, Hansenne I, Moutschen M, Sekaly RP, Cheynier R. Quantification of T-cell receptor rearrangement excision circles to estimate thymic function: an important new tool for endocrine-immune physiology. J Endocrinol 2003; 176: 305-311
67. Kong FK, Kong F, Chen CH, Cooper MD. Thymic function can be accurately monitored by the level of recent T-cell emigrants in the circulation. Immunity 1998; 8: 97-104
68. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Jamieson BD, Zack JA, Picker LJ, Koup RA. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 396: 690-695
69. Poulin JF, Viswanathan MN, Harris JM, Kumanduri KV, Wieder E, Rinquette N, Jenkins M, McCune JM, Sekaly RP. Direct evidence for thymic function in adult humans. J Exp Med 1999; 190: 479-486
70. McEndy DP, Boon MC, Furth J. On the role of thymus, spleen, and gonads in the development of leukemia in a high-leukemia stock of mice. Cancer Res 1944; 4: 377-383
71. Metcalf D. In: Outstanding Papers in Biology. London: Current Biology Ltd, 1993: 117-124
72. Petridou E, Klimentopoulou AE, Moustaki M, Kostrikis LG, Hatzakis A, Trichopoulos D. Recent thymic emigrants and prognosis in T- and B-cell childhood hematopoietci malignancies. Int J Cancer 2002; 101: 74-77
73. von Boehmer H, Aifantis I, Feinberg J, Lechner O, Saint-Ruf C, Walter U, Buer J, Azogui O. Pleiotropic changes controlled by the pre-T-cell receptor. Curr Opin Immunol 1999; 11: 135-142
74. Jameson S, Bevan M. T-cell selection. Curr Opin Immunol 1998; 10: 214-219
75. Bellavia D, Campese AF, Alesse E, Vacca A, Felli MP, Balestri A, Stoppacciaro A, Tiveron C, Tatangelo L, Giovarelli M, Gaetano C, Ruco L, Hoffman ES, Hayday AC, Lendahl U, Frati L, Gulino A, Screpanti I. Constitutive activation of NF-κB and T-cell leukemia/lymphoma in Notch3 transgenic mice. EMBO J 2000; 19: 3337-3348
76. Bellavia D, Campese AF, Checquolo S, Balestri A, Biondi A, Cazzaniga G, Lendahl U, Fehling HJ, Hayday AC, Frati L, von Boehmer H, Gulino A, Screpanti I. Combined expression of pToc and Notch3 in T-cell leukemia identifies the requirement of preTCR for leukemogenesis. Proc Natl Acad Sci USA 2002; 99: 3788-2793
77. Amsen D, Kruisbeek AM. Thymocyte selection: not by TCR alone. Immunol Rev 1998; 165: 209-229
78. Pansky B, House EL, Cone LA. An insulin-like thymic factor. A preliminary report. Diabetes 1965; 14: 325-332
79. Silverstein MN, Wakim K, Bahn RC, Bayrd ED. A hypoglycemic factor in leukemic tumors. Proc Soc Exp Biol Med 1960; 103: 824-826
80. Zapf J, Hauri C, Waldvogel M, Froesch ER. Acute metabolic effects and half-lives of intravenously administered insulin-like growth factors I and II in normal and hypophectomised rats. J Clin Invest 1986; 77: 1768-1775
81. Kooijman RK, Scholtens LE, Rijkers GT, Zegers BJ. Differential expression of type I insulin-like growth factor receptors in different stages of human T-cells. Eur J Immunol. 1995; 25: 931-935
82. Hansenne I, Rasier G, Charlet-Renard C, Defresne MP, Greimers R, Breton C, Legros JJ, Geenen V, Martens H. Neurohypophysial receptor gene expression by thymic T-cell subsets and thymic T-cell lymphoma cell lines. Dev Immunol 2003; in press
83. Mason DY. Seventh Workshop on Human Leukocyte Differentiation Antigens, 2000